256 related articles for article (PubMed ID: 18772221)
1. Brain cholinergic impairment in liver failure.
García-Ayllón MS; Cauli O; Silveyra MX; Rodrigo R; Candela A; Compañ A; Jover R; Pérez-Mateo M; Martínez S; Felipo V; Sáez-Valero J
Brain; 2008 Nov; 131(Pt 11):2946-56. PubMed ID: 18772221
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis.
Ballmaier M; Casamenti F; Scali C; Mazzoncini R; Zoli M; Pepeu G; Spano PF
Neuroscience; 2002; 114(1):91-8. PubMed ID: 12207957
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain.
Tayebati SK; Di Tullio MA; Amenta F
Clin Exp Hypertens; 2004 May; 26(4):363-73. PubMed ID: 15195690
[TBL] [Abstract][Full Text] [Related]
4. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation.
García-Ayllón MS; Silveyra MX; Candela A; Compañ A; Clària J; Jover R; Pérez-Mateo M; Felipo V; Martínez S; Galcerán J; Sáez-Valero J
Hepatology; 2006 Mar; 43(3):444-53. PubMed ID: 16496349
[TBL] [Abstract][Full Text] [Related]
5. Choline acetyltransferase and acetylcholinesterase activities are unchanged in brain in human and experimental portal-systemic encephalopathy.
Rao VL; Therrien G; Butterworth RF
Metab Brain Dis; 1994 Dec; 9(4):401-7. PubMed ID: 7898405
[TBL] [Abstract][Full Text] [Related]
6. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
[TBL] [Abstract][Full Text] [Related]
7. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.
Jover R; Rodrigo R; Felipo V; Insausti R; Sáez-Valero J; García-Ayllón MS; Suárez I; Candela A; Compañ A; Esteban A; Cauli O; Ausó E; Rodríguez E; Gutiérrez A; Girona E; Erceg S; Berbel P; Pérez-Mateo M
Hepatology; 2006 Jun; 43(6):1257-66. PubMed ID: 16729306
[TBL] [Abstract][Full Text] [Related]
8. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.
Amenta F; Tayebati SK; Vitali D; Di Tullio MA
Mech Ageing Dev; 2006 Feb; 127(2):173-9. PubMed ID: 16297435
[TBL] [Abstract][Full Text] [Related]
9. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia.
Muthuraju S; Maiti P; Solanki P; Sharma AK; Amitabh ; Singh SB; Prasad D; Ilavazhagan G
Behav Brain Res; 2009 Oct; 203(1):1-14. PubMed ID: 19446892
[TBL] [Abstract][Full Text] [Related]
11. Locomotor and sensorimotor performance deficit in rats following exposure to pyridostigmine bromide, DEET, and permethrin, alone and in combination.
Abou-Donia MB; Goldstein LB; Jones KH; Abdel-Rahman AA; Damodaran TV; Dechkovskaia AM; Bullman SL; Amir BE; Khan WA
Toxicol Sci; 2001 Apr; 60(2):305-14. PubMed ID: 11248143
[TBL] [Abstract][Full Text] [Related]
12. Heavy metal uranium affects the brain cholinergic system in rat following sub-chronic and chronic exposure.
Bensoussan H; Grancolas L; Dhieux-Lestaevel B; Delissen O; Vacher CM; Dublineau I; Voisin P; Gourmelon P; Taouis M; Lestaevel P
Toxicology; 2009 Jun; 261(1-2):59-67. PubMed ID: 19409444
[TBL] [Abstract][Full Text] [Related]
13. Minocycline restores cognitive-relative altered proteins in young bile duct-ligated rat prefrontal cortex.
Li SW; Chen YC; Sheen JM; Hsu MH; Tain YL; Chang KA; Huang LT
Life Sci; 2017 Jul; 180():75-82. PubMed ID: 28366719
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia.
Zugno AI; Julião RF; Budni J; Volpato AM; Fraga DB; Pacheco FD; Deroza PF; Luca RD; de Oliveira MB; Heylmann AS; Quevedo J
Metab Brain Dis; 2013 Sep; 28(3):501-8. PubMed ID: 23775300
[TBL] [Abstract][Full Text] [Related]
15. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
[TBL] [Abstract][Full Text] [Related]
16. Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.
Scacchi R; Gambina G; Moretto G; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):502-7. PubMed ID: 18780301
[TBL] [Abstract][Full Text] [Related]
17. Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice.
Liu W; Zhu Y; Wang Y; Qi S; Wang Y; Ma C; Li S; Jiang B; Cheng X; Wang Z; Xuan Z; Wang C
J Ethnopharmacol; 2017 May; 204():95-106. PubMed ID: 28442406
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of N-acetyl-L-cysteine on oxidative stress and cognitive impairment in hepatic encephalopathy following bile duct ligation.
Dhanda S; Kaur S; Sandhir R
Free Radic Biol Med; 2013 Mar; 56():204-15. PubMed ID: 23044263
[TBL] [Abstract][Full Text] [Related]
19. Huperzine A protects sepsis associated encephalopathy by promoting the deficient cholinergic nervous function.
Zhu SZ; Huang WP; Huang LQ; Han YL; Han QP; Zhu GF; Wen MY; Deng YY; Zeng HK
Neurosci Lett; 2016 Sep; 631():70-78. PubMed ID: 27400829
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of acetylcholinesterase inhibitor in the senescent rat brain.
Tanaka K; Ogawa N; Asanuma M; Kondo Y; Mori A
Neurobiol Aging; 1994; 15(6):721-5. PubMed ID: 7891827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
